Hainan Project Updates and Next Steps

Asian American Medical Group Limited

6 December 2019

Melbourne, Australia

1

2

3

4

5

Hainan Boao Lecheng International Medical Pilot Zone ("Pilot Zone")

The Pilot Zone offers incentives and special policies that are not available elsewhere within China. Selected examples:

Shorten processing time for importing medical devices: 30-40 days faster

Medical devices

Reduced duty rates

Simplified approval process for large-scale medical devices

Importation of

Special & fast-track approval for drugs unregistered in China, but approved by

foreign authorities

medicines

Reduced duty rates

Foreign investments

Gradual easing of foreign ownership restrictions

in medical

Long term goal: Special approval for 100% foreign-owned medical institutions

institutions

Foreign physicians &

Longer practicing period for foreigners: Up to 5 years, instead of 1.

workers

Facilitation of work permits for selected medical professionals/management

Medical R&D

Special approval for stem cells & genomics research

AAMG's Hainan Clinic in BIH

Liver Diseases in China

Of the 350 million to 400 million individuals worldwide infected with the hepatitis B virus

("HBV"), one-third reside in China, with 130 million carriers and 30 million chronically infected.

During a 5-year period, 10.0% of patients with chronic hepatitis will develop cirrhosis, 20.3% of

the cases will progress to decompensated cirrhosis and 6.5% of the people with cirrhosis and chronic hepatitis will develop hepatocellular carcinoma ("HCC"). 5-year survival for compensated cirrhosis is 55%, that for decompensated cirrhosis is 14%, and that for HCC is less

than 5%. Every year, 300,000 people die from HBV-related diseases in China, including 180,000

patients with HCC. Since the Expanded Program on Immunization ("EPI") beginning 1992, the prevalence of HBV has declined, especially among children 3 to 12 years old. However, the incidence of hepatitis B is still increasing, from 21.9 in 100,000 people in 1990 to 53.3 in 100,000 in 2003. This increase has occurred because of better screening programmes.

China Aesthetic Market

  • China's Market for Beauty Care & Aesthetic Medical Expected to Exceed US$150bn from Plastic Surgery to Home Beauty & Medical Devices

Updates on collaborations in Hainan

------------------------------------------------

Signed Letter of Intent ("LOI") with King's College in

Sept 2019, followed by a Summary of Commercial

Terms in Nov 2019. Currently working on the definitive

------------------------------------------------agreement.

Signed LOI with Dream Plastics Surgery in Oct 2019. Currently working on the financial model and definitive agreement.

------------------------------------------------

LOI signed in Sept 2019 with Hainan Boao Lecheng International Medical Tourism Pilot Zone Development and Construction Co., Ltd., the investment platform company jointly invested by China Merchants Group, Qionghai Municipal People's Government and Hainan

Development Holding Co., Ltd.

------------------------------------------------

Signed LOI with Lahey Hospital & Medical Center in Oct 2019. Currently working on the definitive agreement.

Next steps

  1. Continue to aggressively promote AAMG's Singapore
    Specialists Centre in Hainan through digital and conventional marketing.
  2. Stabalise the liver clinic's revenue and control the cost, continue to support the growth of AARO.
  3. Continue to push, together with the Sultan of Johor 's support, for the 5-acre Iskandar land to be gazetted as a special zone for employment of foreign medical specialists.
  4. Finalise the Joint Ventures for 5-acre Iskandar land in Malaysia, including the collaboration with ROSATOM for a nuclear medicine facility.
  5. In addition to the salary cost cutting in Jan 2018 and May 2019, further reduction of 20%-40% in 1st quarter of 2020.
  6. Human resource rationalisation which will include retrenchments and redesignations.
  7. Reduction in clinic and office space to lower rental cost.

Thank you!

Attachments

  • Original document
  • Permalink

Disclaimer

Asian American Medical Group Limited published this content on 06 December 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 06 December 2019 02:00:04 UTC